People · Operator
Named in public records as an officer, director or promoter · active 2020–2022 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Regenacy Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $28.7M | $142.6M | 2020 |
Michael L. Huang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael L. Huang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Marc Cohen | 1 | 6 |
| Simon Jones | 1 | 2 |
| Daguang L. Wang | 1 | 1 |
| William L. Chin | 1 | 1 |
| Shixiang L. Yan | 1 | 1 |
| John Rocha | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.